speb/financial-data huggingface dataset:
IPC.L balance_sheet (annual, 2025-12-31) — Working Capital: 2207000000.00
IPC.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 2207000000.00
IPC.L income_statement (quarterly, 2026-03-31) — +Operating Expense: 1553000000.00
IPC.L income_statement (quarterly, 2026-03-31) — +Total Revenue: 5971000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3833000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3519000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -18600000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 14352000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -72000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 85000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Basic Average Shares: 545454545.00
IPC.L income_statement (quarterly, 2026-03-31) — Basic EPS: 0.11
IPC.L cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1161000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -517000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 450000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Capital Stock: 627000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1236000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1236000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -245000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1019000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 565000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 611000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -272000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 158000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Interest Payable: 158000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Inventory: 58000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 217000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Payable: -272000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -114000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Receivables: -197000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -36000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -158000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Changes In Cash: 157000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Common Stock: 627000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -245000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 14808000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -30000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4244000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 693000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Current Assets: 8580000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Current Debt: 918000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 918000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7073000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 507000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 489000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 489000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 489000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 489000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 545454545.00
IPC.L income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.11
IPC.L income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 60000000.00
IPC.L income_statement (quarterly, 2026-03-31) — EBIT: 225000000.00
IPC.L income_statement (quarterly, 2026-03-31) — EBITDA: 714000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 0.00
IPC.L cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -11000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 428000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — End Cash Position: 1307000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1019000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Finished Goods: 724000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 94000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 3000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
IPC.L income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 0.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -366000000.00
IPC.L income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 510000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Goodwill: 5297000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 9357000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3591000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Gross PPE: 33504000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Gross Profit: 1727000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Interest Expense: 132000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 132000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Interest Income: 56000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 56000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 84000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Inventory: 1902000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Invested Capital: 23901000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 565000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2354000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2354000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 450000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 8175000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 8625000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
IPC.L cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -660000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 1059000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -30000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Net Debt: 7857000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income: 60000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 60000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 76000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -16000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 60000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 76000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 60000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 60000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Interest Income: -76000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -660000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -660000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -76000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -84000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 2000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Net PPE: 14904000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -496000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5451000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1963000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1963000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 428000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 737000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Normalized Income: 94860000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 503000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 611000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 16000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Operating Income: 174000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Operating Revenue: 5971000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 529400000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Inside Changein Cash: 0.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 602000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1629000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -366000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Other Gand A: 510000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Other Income Expense: -5000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4060000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Inventories: 74000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 75000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 732000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 3537000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 18000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Properties: 33504000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Other Receivables: 670000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Other Taxes: 41000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Payables: 3833000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4526000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 13000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Pretax Income: 93000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -517000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1104000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Receivables: 4692000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4244000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 489000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -660000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -30000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 63000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 23000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 4699000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Sale Of Business: 1059000000.00
IPC.L cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 21000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 513000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1023000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Share Issued: 627000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Special Income Charges: -23000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 14808000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5451000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -4140000.00
IPC.L income_statement (quarterly, 2026-03-31) — Tax Provision: 17000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Assets: 36434000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 22983000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Debt: 9543000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 14808000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Total Expenses: 5797000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 21626000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 27854000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14553000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Total Unusual Items: -23000000.00
IPC.L income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -23000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 97600000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 4504000000.00
IPC.L balance_sheet (quarterly, 2026-03-31) — Working Capital: 1507000000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -11890700000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -12600000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Amortization: 202200000.00
IPCALAB.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 202200000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 104600000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 253704218.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Basic EPS: 34.85
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 7140100000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 2030000000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 721900000.00
IPCALAB.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 183300000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 253704218.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Diluted EPS: 34.85
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 12900000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 400000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 7260300000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 736500000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 9120400000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 0.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Interest Income: 341700000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 341700000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 2370700000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 76200000.00
IPCALAB.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 2156600000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 22903600000.00
IPCALAB.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 5400000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 596400000.00
IPCALAB.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 41200000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 491800000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Other Payable: 1307800000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 679300000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 642700000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 7248400000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 154700000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 154700000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Research And Development: 417900000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 122900000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 40360600000.00
IPCALAB.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 28400000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 3696800000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 4433300000.00
IPCALAB.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 39600000.00
IPCALAB.NS balance_sheet (annual, 2022-03-31) — Work In Process: 3579200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — +Operating Expense: 30945800000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — +Total Revenue: 62068500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 5250600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9890200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -14306200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -6800000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Amortization: 253700000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 253700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 253700000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 253704218.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Basic EPS: 18.58
IPCALAB.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 9909300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 8182500000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -4944700000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 237400000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 12578500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 21790700000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -1014800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 11661700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 916800000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 1146000000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 422300000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -127900000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Change In Payable: -324000000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -681000000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 489900000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 5880500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 58420200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1592200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 24075100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Assets: 51892700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 66600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Debt: 8057500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 8124100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 227600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 18058200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 1080300000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Depreciation: 2615600000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 2615600000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 2615600000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2361900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 253704218.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Diluted EPS: 18.58
IPCALAB.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 4713200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 14000000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — EBIT: 7903800000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — EBITDA: 10519400000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — End Cash Position: 15789800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 400000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 5072400000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 6563500000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 3113400000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 13800000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -132100000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 761900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Goodwill: 381400000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1972300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 9897000000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 41622500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Gross Profit: 37993400000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Interest Expense: 450900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 450900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Interest Income: 793500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 793500000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -414800000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 542300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Inventory: 17433700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 72995500000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -7250000000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 254100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Investments In Other Ventures Under Equity Method: 1298100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 1300000000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 174400000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 3916900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2144800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 170800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 6517800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 6688600000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 3916900000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -282500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 2772500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 469900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 27671400000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 733000000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Minority Interests: -76700000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -559300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1996800000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 187000000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Income: 4713200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 4713200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 4789900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 4713200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 4713200000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 7452900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 4789900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Interest Income: 311600000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 6577100000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 3634400000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 311600000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -2000000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -2293400000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 27316300000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -4583200000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 2942700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 56447900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 2800000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 35700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1891600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 781800000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 10263100000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Normalized Income: 4544028725.73
IPCALAB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 8058100000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Operating Income: 7047600000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 62068500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 253704218.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 57400000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 690200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: -271300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1590900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 583200000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -338100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 3100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 24748500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 152500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 7749300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 2448200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 2031600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 976200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 9212200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Other Special Charges: -132100000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Payables: 8053100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 781700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 664900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Pretax Income: 7452900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -2800000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -559300000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -4944700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 7017700000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 24075100000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 2615600000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 164100000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 164100000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -282500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Research And Development: 461300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 84900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 44040100000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 361500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 5561700000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 6323600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 253704218.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Special Income Charges: 106600000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 0.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 58420200000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 56447900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 87128725.73
IPCALAB.NS income_statement (annual, 2023-03-31) — Tax Provision: 2533600000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.34
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 994700000.00
IPCALAB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -2236500000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 86264300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 64938000000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 14812700000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 59153200000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Total Expenses: 55020900000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 27111100000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 34371600000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 9052900000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 31000000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 340300000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 256300000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 256300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Work In Process: 3269300000.00
IPCALAB.NS balance_sheet (annual, 2023-03-31) — Working Capital: 33834500000.00
IPCALAB.NS income_statement (annual, 2023-03-31) — Write Off: 25500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 39621500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 76224100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 7760800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 16865100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -22534500000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -38300000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Amortization: 241600000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 241600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 33500000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 265000000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 253704218.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Basic EPS: 21.57
IPCALAB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 15789800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 13581500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -4112900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -6900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 508600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 2089100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 8524400000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -507400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 701200000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1387900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -947000000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -149500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 814300000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Change In Payable: 214900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -758000000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -915900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -8996900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 63321900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 3565300000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 27257900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 55389000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 109300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 8070900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 8180200000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 431400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 23556400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 2445600000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 3330800000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 3572400000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 3572400000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 3330800000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 253704218.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 21.57
IPCALAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 5473500000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 28000000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — EBIT: 9799600000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — EBITDA: 13372000000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 7557900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 600000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -5525500000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 10127700000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 5333600000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -725500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -34900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1174000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Goodwill: 905800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2331800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 16903400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 69494900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 48966200000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 1372900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1372900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Interest Income: 629300000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 629300000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1342500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 808800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 24713100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 77196900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -12917900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 265600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Investments In Other Ventures Under Equity Method: 1570200000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 1085400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 1764500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 1237100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 6458400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 399300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 5804100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 6203400000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 1237100000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -1767600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 2849900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 868400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 43724300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 13948100000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Minority Interests: 244300000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -15679600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Net Debt: 11785900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -72000000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Income: 5473500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 5473500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 5229200000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 5473500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 5473500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 8426700000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 5229200000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: -778200000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 647800000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -3568800000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -530500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -778200000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 5099600000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 46960400000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -4019800000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -3038300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 60990100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 1200000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 42300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 3104700000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1960800000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 13906400000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Normalized Income: 5809111596.47
IPCALAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 9446500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Operating Income: 9344700000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 76224100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 253704218.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 765000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 99200000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 1222300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: -255200000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1426000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 836500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 759100000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 214900000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 9900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 65100000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 9476800000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 3367000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2165400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 1030400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 6435300000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Other Special Charges: 573500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Payables: 12038000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 2779500000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Pretax Income: 8426700000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 1368900000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -15679600000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -4106000000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 9578900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 27257900000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 3572400000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 193000000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 193000000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1767600000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Research And Development: 718300000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 28000000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 390400000.00
IPCALAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 48993500000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 647800000.00
IPCALAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 86200000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 7086300000.00
IPCALAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 8260300000.00